This archive contains links to the full-text of all issues of Clin Mol Hepatol.
First decision
09 Days
Publication after acceptance
04 Days
*Last 12 months
Viewed By 5387 |
Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment |
Viewed By 5341 |
MAFLD: How is it different from NAFLD? |
Viewed By 5231 |
Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma |
Viewed By 3912 |
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma |
Viewed By 3878 |
Global incidence and prevalence of nonalcoholic fatty liver disease |
Cited By 114 |
Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma |
Cited By 103 |
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma |
Cited By 76 |
Global incidence and prevalence of nonalcoholic fatty liver disease |
Cited By 65 |
Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach |
Cited By 52 |
MAFLD: How is it different from NAFLD? |